New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study.

Bell R, Pandanaboyana S, Lodge JPA, et al (2017). Primary

liver resection for patients with cirrhosis and hepatocellular

carcinoma: the role of surgery in BCLC early (A) and

intermediate stages (B). Langenbecks Arch Surg, 402,

575-83.

Bolondi L, Burroughs A, Dufour JF, et al (2012). Heterogeneity

of patients with intermediate (BCLC B) Hepatocellular

Carcinoma: proposal for a subclassification to facilitate

treatment decisions. Semin Liver Dis, 32, 348-59.

Bruix J, Gores GJ, Mazzaferro V (2014). Hepatocellular

2910

Asian Pacific Journal of Cancer Prevention, Vol 21

carcinoma: clinical frontiers and perspectives. Gut, 63,

844-55.

Ciria R, Lopez-Cillero P, Gallardo AB, et al (2015). Optimizing the

management of patients with BCLC stage-B hepatocellular

carcinoma: Modern surgical resection as a feasible

alternative to transarterial chemoemolization. Eur J Surg

Oncol, 41, 1153-61.

D’Avola D, Inarrairaegui M, Pardo F, et al (2011). Prognosis

of hepatocellular carcinoma in relation to treatment across

BCLC stages. Ann Surg Oncol, 18, 1964-71.

de Lope CR, Tremosini S, Forner A, et al (2012). Management

of HCC. J Hepatol, 56, 75-87.

Dindo D, Demartines N, Clavien PA (2004). Classification of

surgical complications: a new proposal with evaluation in

a cohort of 6336 patients and results of a survey. Ann Surg,

240, 205-13.

Forner A, Llovet JM, Bruix J (2012). Hepatocellular carcinoma.

Lancet, 379, 1245-55.

Fukami Y, Kaneoka Y, Maeda A, et al (2019). Liver resection for

multiple hepatocellular carcinomas: A Japanese Nationwide

Survey. Ann Surg, 10.1097/SLA.0000000000003192.

Furukawa K, Shiba H, Horiuchi T, et al (2017). Survival benefit

of hepatic resection for hepatocellular carcinoma beyond the

Barcelona Clinic Liver Cancer classification. J Hepatobiliary

Pancreat Sci, 24, 199-205.

Galle PR, Tovoli F, Foerster F, et al (2017). The treatment of

intermediate stage tumours beyond TACE: From surgery to

systemic therapy. J Hepatol, 67, 173-83.

Hiraoka A, Kumada T, Nouso K, et al (2016). Proposed new subgrouping for intermediate-stage hepatocellular carcinoma

using albumin-bilirubin grade. Oncology, 91, 153-61.

Ho MC, Hasegawa K, Chen XP, et al (2016). Surgery for

intermediate and advanced hepatocellular carcinoma: A

Consensus Report from the 5th Asia-Pacific Primary Liver

Cancer Expert Meeting (APPLE 2014). Liver Cancer, 5,

245-56.

Hyun MH, Lee YS, Kim JH, et al (2018). Hepatic resection

compared to chemoembolization in intermediate- to

advanced-stage hepatocellular carcinoma: A meta-analysis

of high-quality studies. Hepatology, 68, 977-93.

Jianyong L, Lunan Y, Wentao W, et al (2014). Barcelona clinic

liver cancer stage B hepatocellular carcinoma: transarterial

chemoembolization or hepatic resection?. Medicine, 93,

e180-e.

Kamiyama T, Orimo T, Wakayama K, et al (2017). Survival

outcomes of hepatectomy for stage B Hepatocellular

carcinoma in the BCLC classification. World J Surg Oncol,

15, 156.

Kudo M, Arizumi T, Ueshima K, et al (2015). Subclassification

of BCLC B stage hepatocellular carcinoma and treatment

strategies: Proposal of Modified Bolondi’s Subclassification

(Kinki Criteria). Dig Dis, 33, 751-8.

Kudo M, Izumi N, Sakamoto M, et al (2016). Survival Analysis

over 28 Years of 173,378 Patients with Hepatocellular

Carcinoma in Japan. Liver Cancer, 5, 190-7.

Lin CT, Hsu KF, Chen TW, et al (2010). Comparing hepatic

resection and transarterial chemoembolization for Barcelona

Clinic Liver Cancer (BCLC) stage B hepatocellular

carcinoma: change for treatment of choice?. World J Surg,

34, 2155-61.

Liu W, Zhou JG, Sun Y, et al (2015). Hepatic resection improved

the long-term survival of patients with BCLC stage B

hepatocellular carcinoma in Asia: a Systematic Review and

Meta-Analysis. J Gastrointest Surg, 19, 1271-80.

Mazzaferro V, Llovet JM, Miceli R, et al (2009). Predicting

survival after liver transplantation in patients with

hepatocellular carcinoma beyond the Milan criteria: a

DOI:10.31557/APJCP.2020.21.10.2903

Resection Criteria for Intermediate Stage HCC

retrospective, exploratory analysis. Lancet Oncol, 10, 35-43.

Qi X, Wang D, Su C, et al (2015). Hepatic resection versus

transarterial chemoembolization for the initial treatment of

hepatocellular carcinoma: A systematic review and metaanalysis. Oncotarget, 6, 18715-33.

Shimamura T, Akamatsu N, Fujiyoshi M, et al (2019). Expanded

living-donor liver transplantation criteria for patients with

hepatocellular carcinoma based on the Japanese nationwide

survey: the 5-5-500 rule - a retrospective study. Transpl Int,

32, 356-68.

Tada T, Kumada T, Toyoda H, et al (2017). Role of hepatic

resection in patients with intermediate-stage hepatocellular

carcinoma: A multicenter study from Japan. Cancer Sci,

108, 1414-20.

Takada Y, Ito T, Ueda M, et al (2007). Living donor liver

transplantation for patients with HCC exceeding the Milan

criteria: a proposal of expanded criteria. Dig Dis, 25, 299302.

The Japan Society of Hepatology (2013). Clinical Practice

Guidelines for Hepatocellular Carcinoma 2013. Kanehara

Co, Ltd.

Torre LA, Bray F, Siegel RL, et al (2015). Global cancer

statistics, 2012. CA Cancer J Clin, 65, 87-108.

Torzilli G, Belghiti J, Kokudo N, et al (2013). A snapshot of the

effective indications and results of surgery for hepatocellular

carcinoma in tertiary referral centers: is it adherent to the

EASL/AASLD recommendations?: an observational study

of the HCC East-West study group. Ann Surg, 257, 929-37.

Wada H, Eguchi H, Noda T, et al (2016). Selection criteria for

hepatic resection in intermediate-stage (BCLC stage B)

multiple hepatocellular carcinoma. Surgery, 160, 1227-35.

Yamakado K, Kudo M (2014). Treatment strategies of

intermediate-stage hepatocellular carcinomas in Japan

(Barcelona Clinic Liver Cancer stage B). Oncology, 87,

78-81.

Yin L, Li H, Li AJ, et al (2014). Partial hepatectomy vs.

transcatheter arterial chemoembolization for resectable

multiple hepatocellular carcinoma beyond Milan Criteria:

a RCT. J Hepatol, 61, 82-8.

Zhong JH, Ke Y, Gong WF, et al (2014). Hepatic resection

associated with good survival for selected patients with

intermediate and advanced-stage hepatocellular carcinoma.

Ann Surg, 260, 329-40.

Zhong JH, Xiang BD, Gong WF, et al (2013). Comparison

of long-term survival of patients with BCLC stage B

hepatocellular carcinoma after liver resection or transarterial

chemoembolization. PLoS One, 8, e68193.

This work is licensed under a Creative Commons AttributionNon Commercial 4.0 International License.

Asian Pacific Journal of Cancer Prevention, Vol 21

2911

...